Loading data
CRWVNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 5.13 bn USD | 1.92 bn USD | 229 m USD | 15.83 m USD |
| Cost of revenue | 1.45 bn USD | 493 m USD | 69 m USD | 12.12 m USD |
| Research and development expense | 352 m USD | 56 m USD | 21 m USD | 5 m USD |
| Operating profit | -46 m USD | 324 m USD | -14 m USD | -22.88 m USD |
| Profit before tax | -1.22 bn USD | -744 m USD | -558 m USD | -35.02 m USD |
| Income tax expense | -48 m USD | 119 m USD | 36 m USD | -4.15 m USD |
| Net income (reported basis) | -1.17 bn USD | -863 m USD | -594 m USD | -31.06 m USD |
| Net income attributable to common shareholders | -1.2 bn USD | -937 m USD | -594 m USD | -31.06 m USD |
| Basic earnings per share | -2.75 USD/share | -4.3 USD/share | -3.09 USD/share | -0.17 USD/share |
| Diluted earnings per share | -2.81 USD/share | -4.3 USD/share | -3.09 USD/share | -0.17 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.